NCT00501163View on ClinicalTrials.gov

Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients

CompletedOBSERVATIONAL
Enrollment

38

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions
SchizophreniaCardiovascular Disease
Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Washington University School of Medicine

OTHER

NCT00501163 - Direct Measurements of Cardiometabolic Risk in Treated Schizophrenia Patients | Biotech Hunter | Biotech Hunter